VDT Trademark

Trademark Overview

On Monday, September 25, 2017, a trademark application was filed for VDT with the United States Patent and Trademark Office. The USPTO has given the VDT trademark a serial number of 87621614. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, March 27, 2025. This trademark is owned by Akebia Therapeutics, Inc.. The VDT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hematological conditions and diseases, and pharmaceutical preparations for the treatment of chronic conditions, namely, chronic kidney disease, and all types of anemias
vdt

General Information

Serial Number87621614
Word MarkVDT
Filing DateMonday, September 25, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, March 27, 2025
Registration Number5650565
Registration DateTuesday, January 8, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 19, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of hematological conditions and diseases, and pharmaceutical preparations for the treatment of chronic conditions, namely, chronic kidney disease, and all types of anemias

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 29, 2017
Primary Code005
First Use Anywhere DateTuesday, August 14, 2018
First Use In Commerce DateTuesday, August 14, 2018

Trademark Owner History

Party NameAkebia Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAkebia Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAkebia Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Thursday, September 28, 2017NEW APPLICATION ENTERED
Tuesday, November 14, 2017ASSIGNED TO EXAMINER
Friday, September 29, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 20, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, November 14, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 29, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 19, 2017PUBLISHED FOR OPPOSITION
Tuesday, December 19, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 26, 2018SOU TEAS EXTENSION RECEIVED
Thursday, July 26, 2018SOU EXTENSION 1 FILED
Thursday, July 26, 2018SOU EXTENSION 1 GRANTED
Saturday, July 28, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 18, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 20, 2018USE AMENDMENT FILED
Tuesday, December 4, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 4, 2018STATEMENT OF USE PROCESSING COMPLETE
Wednesday, December 5, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, December 6, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 8, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, April 18, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 18, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 18, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 18, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, December 9, 2024TEAS SECTION 8 & 15 RECEIVED
Thursday, March 27, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, March 27, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, March 27, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, January 8, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

pharmaceutical conditions treatment preparations chronic types anemias disease diseases hematological